ARSHEEMA ABDURAHMAN: Open Payments
NPI 1548745060 · PORT ORANGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,213 in 33 payments from 17 companies in 2025. Trend: 2023 $1,466 · 2024 $1,998 · 2025 $1,213
Food & beverage: $1,213
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 2 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $148 |
| Boston Scientific Corporation | 2 | $146 |
| Novo Nordisk Inc | 2 | $143 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $118 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Biosense Webster, Inc. | 3 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| Ascensia Diabetes Care Us Inc. | 1 | $37 |
Products named: Assure WCD, Kerendia, Ozempic, General - Tachy, LifeVest, LEQVIO, CARTO 3, JARDIANCE.
Industry payments across FL — which companies pay providers there.
